Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Disease | 8 | 2023 | 350 | 3.280 |
Why?
|
| Cardiovascular Diseases | 17 | 2023 | 827 | 3.200 |
Why?
|
| Atherosclerosis | 10 | 2023 | 244 | 3.080 |
Why?
|
| Exercise | 6 | 2023 | 315 | 2.090 |
Why?
|
| Vascular Calcification | 3 | 2021 | 39 | 1.560 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 378 | 1.410 |
Why?
|
| Hypertension | 7 | 2023 | 1141 | 1.400 |
Why?
|
| Calcium | 6 | 2023 | 1156 | 1.190 |
Why?
|
| Risk Factors | 22 | 2023 | 5417 | 1.180 |
Why?
|
| Myocardial Infarction | 5 | 2023 | 376 | 1.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2022 | 1373 | 1.060 |
Why?
|
| Cardiology | 2 | 2021 | 123 | 0.850 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2022 | 18 | 0.840 |
Why?
|
| Preventive Medicine | 1 | 2021 | 17 | 0.810 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2021 | 36 | 0.790 |
Why?
|
| Obesity, Abdominal | 2 | 2023 | 8 | 0.790 |
Why?
|
| Body Mass Index | 4 | 2021 | 770 | 0.780 |
Why?
|
| Counseling | 1 | 2022 | 145 | 0.760 |
Why?
|
| Cardiovascular System | 1 | 2021 | 71 | 0.760 |
Why?
|
| Calcinosis | 1 | 2022 | 224 | 0.750 |
Why?
|
| Proprotein Convertase 9 | 1 | 2020 | 20 | 0.740 |
Why?
|
| Thrombosis | 1 | 2023 | 296 | 0.730 |
Why?
|
| Waist Circumference | 1 | 2019 | 20 | 0.730 |
Why?
|
| Electrocardiography | 4 | 2023 | 478 | 0.720 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 159 | 0.710 |
Why?
|
| Antihypertensive Agents | 4 | 2022 | 521 | 0.690 |
Why?
|
| Primary Prevention | 1 | 2019 | 85 | 0.640 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 547 | 0.630 |
Why?
|
| Sleep | 2 | 2023 | 444 | 0.630 |
Why?
|
| Humans | 35 | 2023 | 86643 | 0.560 |
Why?
|
| Cardiac Rehabilitation | 2 | 2023 | 4 | 0.430 |
Why?
|
| Hypolipidemic Agents | 3 | 2023 | 102 | 0.420 |
Why?
|
| Incidence | 5 | 2023 | 1577 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1036 | 0.400 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 3640 | 0.390 |
Why?
|
| American Heart Association | 2 | 2023 | 92 | 0.380 |
Why?
|
| Coronary Angiography | 2 | 2022 | 232 | 0.360 |
Why?
|
| Coronary Vessels | 2 | 2021 | 177 | 0.360 |
Why?
|
| Middle Aged | 13 | 2023 | 25028 | 0.310 |
Why?
|
| Prevalence | 2 | 2022 | 1239 | 0.300 |
Why?
|
| Female | 17 | 2023 | 44532 | 0.290 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 288 | 0.290 |
Why?
|
| Nutrition Surveys | 3 | 2023 | 114 | 0.280 |
Why?
|
| Male | 16 | 2023 | 40965 | 0.270 |
Why?
|
| Cardiologists | 1 | 2023 | 4 | 0.240 |
Why?
|
| Prognosis | 3 | 2020 | 3679 | 0.240 |
Why?
|
| Aged | 8 | 2023 | 18415 | 0.240 |
Why?
|
| Adiposity | 2 | 2023 | 70 | 0.230 |
Why?
|
| United States | 6 | 2023 | 6672 | 0.230 |
Why?
|
| Blood Pressure | 4 | 2023 | 1143 | 0.230 |
Why?
|
| Prospective Studies | 3 | 2021 | 4213 | 0.230 |
Why?
|
| Cardiorespiratory Fitness | 1 | 2021 | 6 | 0.210 |
Why?
|
| Calcium, Dietary | 1 | 2021 | 63 | 0.210 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 222 | 0.210 |
Why?
|
| Heart Failure | 2 | 2023 | 1204 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2023 | 2261 | 0.210 |
Why?
|
| Cause of Death | 2 | 2019 | 277 | 0.200 |
Why?
|
| Education | 1 | 2021 | 58 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6509 | 0.200 |
Why?
|
| Preventive Health Services | 1 | 2021 | 37 | 0.200 |
Why?
|
| Random Allocation | 1 | 2021 | 332 | 0.200 |
Why?
|
| Time Factors | 2 | 2021 | 5210 | 0.200 |
Why?
|
| Accelerometry | 1 | 2021 | 36 | 0.190 |
Why?
|
| Europe | 1 | 2021 | 309 | 0.190 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 54 | 0.190 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 894 | 0.190 |
Why?
|
| Needs Assessment | 1 | 2021 | 154 | 0.180 |
Why?
|
| Carotid Arteries | 1 | 2021 | 127 | 0.180 |
Why?
|
| Telemedicine | 1 | 2023 | 169 | 0.180 |
Why?
|
| Carotid Stenosis | 1 | 2021 | 112 | 0.180 |
Why?
|
| Hypoglycemic Agents | 2 | 2019 | 378 | 0.180 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 161 | 0.170 |
Why?
|
| Exercise Test | 1 | 2019 | 164 | 0.170 |
Why?
|
| Morbidity | 1 | 2019 | 148 | 0.160 |
Why?
|
| Obesity | 2 | 2023 | 963 | 0.160 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 267 | 0.150 |
Why?
|
| High Fidelity Simulation Training | 1 | 2016 | 3 | 0.150 |
Why?
|
| Manikins | 1 | 2016 | 41 | 0.140 |
Why?
|
| Computer-Assisted Instruction | 1 | 2016 | 43 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1169 | 0.140 |
Why?
|
| Survival Rate | 1 | 2019 | 1863 | 0.130 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 859 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 350 | 0.120 |
Why?
|
| Southeastern United States | 2 | 2023 | 8 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 965 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1621 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2019 | 2767 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2357 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 806 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2271 | 0.110 |
Why?
|
| Lipreading | 1 | 1992 | 2 | 0.110 |
Why?
|
| Aptitude | 1 | 1992 | 10 | 0.110 |
Why?
|
| Software | 1 | 2016 | 654 | 0.110 |
Why?
|
| Adult | 5 | 2023 | 25648 | 0.110 |
Why?
|
| Echocardiography | 1 | 2016 | 911 | 0.100 |
Why?
|
| Lipids | 2 | 2023 | 269 | 0.090 |
Why?
|
| Actigraphy | 1 | 2023 | 51 | 0.060 |
Why?
|
| Self Efficacy | 1 | 2023 | 53 | 0.060 |
Why?
|
| Walking | 1 | 2023 | 87 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 51 | 0.050 |
Why?
|
| Life Style | 1 | 2023 | 189 | 0.050 |
Why?
|
| Healthy Lifestyle | 1 | 2021 | 9 | 0.050 |
Why?
|
| Self Report | 1 | 2023 | 288 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2023 | 303 | 0.050 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 41 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2023 | 347 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2019 | 62 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2021 | 695 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 582 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 410 | 0.040 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2016 | 27 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 1186 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 740 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 8489 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 248 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 429 | 0.030 |
Why?
|
| Language Tests | 1 | 1992 | 37 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2601 | 0.020 |
Why?
|
| Reference Values | 1 | 1992 | 674 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1992 | 3612 | 0.020 |
Why?
|
| Child | 1 | 1992 | 6927 | 0.010 |
Why?
|